Biotech

All Articles

Navigator rears $100M to establish new autoimmune pipeline

.Sat nav Medicines has actually furnished on its own with $100 thousand in collection A funds as the...

Duality finds cash money for ADC tests as IPO wave infects Asia

.China's Duplicity Biotherapeutics has filed (PDF) documentation for a Hong Kong IPO, looking for a ...

YolTech sells China legal rights to genetics editing and enhancing treatment for $29M

.4 months after Mandarin gene modifying firm YolTech Therapeutics took its own cholesterol levels di...

Addex stock increases after Indivior provides to $300M for substance

.Indivior is actually grabbing a little particle allosteric modulator tailored to treat drug use ail...

Molecular Partners adjusts AML trial over 'suboptimal exposure'

.Molecular Partners has actually determined "suboptimal visibility" to its tetra-specific T-cell eng...

Despite mixed market, a venture capital resurgence might be can be found in Europe: PitchBook

.While the biotech investment performance in Europe has slowed quite observing a COVID-19 backing bo...

8 months after a $213M fundraise, gene editor Volume helps make cuts

.After rearing $213 thousand in 2023-- among the year's largest private biotech rounds-- Volume Bios...

BioMarin creates officer staff with biotech veterinarians-- Chutes &amp Ladders

.Accept to this week's Chutes &amp Ladders, our roundup of notable leadership hirings, firings and a...

Biopharma Q2 VC reached highest degree because '22, while M&ampA slowed

.Equity capital financing into biopharma cheered $9.2 billion across 215 sell the 2nd quarter of thi...

Bicara, Zenas find IPOs to drive late-phase possessions toward market

.Bicara Rehabs and also Zenas Biopharma have actually provided new motivation to the IPO market alon...